Midi Health vs Ro
Midi Health and Ro sell different medications; this is what separates them.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Midi Health
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Midi Health →
Ro
Best for: knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC
Visit Ro →If you are choosing between Midi Health and Ro, price alone will not settle it. Ro leads our six-part score, 6.7 to 4.6.
Midi Health vs Ro price
Ro publishes $149 a month. Midi Health does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.
Medications and formats
Ro lists orforglipron; Midi Health does not name its drug.
On format, Midi Health posts no priced format, while Ro prices brand-name pens.
If you want the FDA-approved brand rather than a compounded version, Ro is the only one of the two with a brand-name price.
Where each one treats patients
Midi Health lists 50 states, and Ro does not publish where it ships.
Pricing
Midi Health
Per-visit self-pay fee, NOT a monthly medication price; GLP-1 medication billed separately or through insurance. No compounded medication price is published on the current site.
Per-visit self-pay fee; medication not included. Under insurance you instead pay your standard copay + deductible.
Ro
Additional membership fees apply
What each price covers
Ro's price also covers the clinician visit, lab work and coaching, which Midi Health does not claim.
Midi Health does not say what its price includes.
Ro is silent on shipping.
Midi Health
Inclusions not disclosed.
Ro
Covered by the monthly price
Medication
Charged on top
Clinician visits
In the price
Shipping
Not stated
Lab work
In the price
Coaching
In the price
Where each one scores higher
Overall, Ro scores 6.7 and Midi Health 4.6 out of 10.
Midi Health is stronger on accessibility (10.0 vs 5.0).
Ro is stronger on value (5.0 vs 3.0), effectiveness (8.0 vs 5.0), user experience (8.0 vs 2.5), trust & safety (8.0 vs 5.0) and support (5.5 vs 5.0).
Midi Health
4.6/10
Ro
6.7/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Midi Health nor Ro has an FDA warning letter on record with us.
Features & Coverage
| Feature | Midi Health | Ro |
|---|---|---|
| Starting Price | Not published | $149/mo |
| Features | 5 features | ✓7 features |
| States Available | 50 | Not disclosed |
| Compounded | — | — |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Midi Health
Medicare, Medicaid, and Medi-Cal are all refused at Midi Health, though commercial insurance is taken. The platform covers menopause and perimenopause nationwide, in 50 states. GLP-1s are not sold here as a standalone weight-loss product; a clinician may add one at their discretion, a metabolic-health adjunct inside the menopause care framework.
Read our full Midi Health review →About Ro
Foundayo (orforglipron), the new oral GLP-1 from Eli Lilly, joined Ro on April 9 2026 at $149/month for the lowest dose, membership on top. Beside it sit compounded semaglutide and the brand-name pair, Zepbound and Wegovy. No obesity care formulary in the category is more comprehensive. In the US, only a handful of direct-to-patient telehealth companies are larger.
Read our full Ro review →Pros & Cons
Midi Health
What we like
- Serves all 50 states
- We found no FDA warning letters issued to Midi Health
- A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Ro
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits, lab work and coaching
- Names Roman Health Pharmacy LLC as the pharmacy that fills its prescriptions, which most sellers do not
- We found no FDA warning letters issued to Ro
Watch-outs
- Not included in the monthly price: medication
- Confirm it serves your state before you start the intake
Our Verdict
Ro wins this one, 6.7 to 4.6, above all for knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC. Midi Health fits better if coverage in all 50 states, which most sellers will not confirm is your priority.
Choose Midi Health if…
You want coverage in all 50 states, which most sellers will not confirm.
Choose Ro if…
You want knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC and an opening price near $149 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
From $59/mo
Get started →Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →Breeze Meds
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $199/mo
Get started →Midi Health vs Ro: FAQ
Close alternatives to Midi Health and Ro
- Midi Health vs Embody
- Midi Health vs TrimRx
- Midi Health vs Henry Meds
- Midi Health vs Hims
- Ro vs Amazon One Medical
- Ro vs LillyDirect Foundayo
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.